Health Care AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4% 10 months ago Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues… Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expect 10 months ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in health and wellness services, is preparing to report second-quarter results,… OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness 10 months ago OS Therapies (NYSE: OSTX) is a cancer immunotherapy company engaged in the development of new treatments for osteosarcoma and other… Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance 11 months ago Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided… Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25 11 months ago Biotechnology company Illumina, Inc. (NASDAQ: ILMN) has issued fresh earnings guidance for fiscal 2025, to reflect tariff-related challenges to export.… Earnings Summary: Highlights of CooperCompanies (COO) Q1 2025 results 11 months ago Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in… Earnings Summary: Highlights of Baxter International’s Q4 2024 report 12 months ago Baxter International Inc. (NYSE: BAX) on Thursday announced financial results for the fourth quarter of 2024. The medical device maker's… MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit 12 months ago Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third… Earnings Summary: Moderna slips to loss in Q4; revenue down 66% 12 months ago Biotechnology company Moderna, Inc. (NASDAQ: MRNA) has reported a net loss for the fourth quarter of 2024, compared to a… Earnings: CVS Health reports a sharp fall in Q4 profit; revenue up 4% 12 months ago Healthcare conglomerate CVS Health Corporation (NYSE: CVS) reported mixed results for the fourth quarter of 2024, with revenues growing modestly… Next» « Previous